152 related articles for article (PubMed ID: 10449444)
1. The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.
Menten P; Struyf S; Schutyser E; Wuyts A; De Clercq E; Schols D; Proost P; Van Damme J
J Clin Invest; 1999 Aug; 104(4):R1-5. PubMed ID: 10449444
[TBL] [Abstract][Full Text] [Related]
2. The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.
Aquaro S; Menten P; Struyf S; Proost P; Van Damme J; De Clercq E; Schols D
J Virol; 2001 May; 75(9):4402-6. PubMed ID: 11287590
[TBL] [Abstract][Full Text] [Related]
3. Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils.
Struyf S; Menten P; Lenaerts JP; Put W; D'Haese A; De Clercq E; Schols D; Proost P; Van Damme J
Eur J Immunol; 2001 Jul; 31(7):2170-8. PubMed ID: 11449371
[TBL] [Abstract][Full Text] [Related]
4. LD78beta, a non-allelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor interactions and potent HIV suppressive activity.
Nibbs RJ; Yang J; Landau NR; Mao JH; Graham GJ
J Biol Chem; 1999 Jun; 274(25):17478-83. PubMed ID: 10364178
[TBL] [Abstract][Full Text] [Related]
5. Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist.
Proost P; Menten P; Struyf S; Schutyser E; De Meester I; Van Damme J
Blood; 2000 Sep; 96(5):1674-80. PubMed ID: 10961862
[TBL] [Abstract][Full Text] [Related]
6. Enhanced anti-HIV-1 activity of CC-chemokine LD78beta, a non-allelic variant of MIP-1alpha/LD78alpha.
Xin X; Shioda T; Kato A; Liu H; Sakai Y; Nagai Y
FEBS Lett; 1999 Aug; 457(2):219-22. PubMed ID: 10471782
[TBL] [Abstract][Full Text] [Related]
7. Proteolysis of macrophage inflammatory protein-1alpha isoforms LD78beta and LD78alpha by neutrophil-derived serine proteases.
Ryu OH; Choi SJ; Firatli E; Choi SW; Hart PS; Shen RF; Wang G; Wu WW; Hart TC
J Biol Chem; 2005 Apr; 280(17):17415-21. PubMed ID: 15728180
[TBL] [Abstract][Full Text] [Related]
8. Macrophage inflammatory protein-1.
Menten P; Wuyts A; Van Damme J
Cytokine Growth Factor Rev; 2002 Dec; 13(6):455-81. PubMed ID: 12401480
[TBL] [Abstract][Full Text] [Related]
9. I-TAC/CXCL11 is a natural antagonist for CCR5.
Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of macrophage inflammatory protein-1alpha, macrophage inflammatory protein-1beta, and RANTES by Candida albicans and Cryptococcus neoformans in peripheral blood mononuclear cells from persons with and without human immunodeficiency virus infection.
Huang C; Levitz SM
J Infect Dis; 2000 Feb; 181(2):791-4. PubMed ID: 10669379
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
[TBL] [Abstract][Full Text] [Related]
12. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
[TBL] [Abstract][Full Text] [Related]
13. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines.
Margolis LB; Glushakova S; Grivel JC; Murphy PM
J Clin Invest; 1998 May; 101(9):1876-80. PubMed ID: 9576751
[TBL] [Abstract][Full Text] [Related]
14. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
[TBL] [Abstract][Full Text] [Related]
15. Chemokine PARC gene (SCYA18) generated by fusion of two MIP-1alpha/LD78alpha-like genes.
Tasaki Y; Fukuda S; Iio M; Miura R; Imai T; Sugano S; Yoshie O; Hughes AL; Nomiyama H
Genomics; 1999 Feb; 55(3):353-7. PubMed ID: 10049593
[TBL] [Abstract][Full Text] [Related]
16. Increased CCR5 expression with decreased beta chemokine secretion in Ethiopians: relevance to AIDS in Africa.
Kalinkovich A; Weisman Z; Leng Q; Borkow G; Stein M; Greenberg Z; Zlotnikov S; Eitan S; Bentwich Z
J Hum Virol; 1999; 2(5):283-9. PubMed ID: 10551734
[TBL] [Abstract][Full Text] [Related]
17. TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans.
Baba M; Takashima K; Miyake H; Kanzaki N; Teshima K; Wang X; Shiraishi M; Iizawa Y
Antimicrob Agents Chemother; 2005 Nov; 49(11):4584-91. PubMed ID: 16251299
[TBL] [Abstract][Full Text] [Related]
18. Identification of amino acid residues critical for LD78beta, a variant of human macrophage inflammatory protein-1alpha, binding to CCR5 and inhibition of R5 human immunodeficiency virus type 1 replication.
Miyakawa T; Obaru K; Maeda K; Harada S; Mitsuya H
J Biol Chem; 2002 Feb; 277(7):4649-55. PubMed ID: 11734558
[TBL] [Abstract][Full Text] [Related]
19. Aminooxypentane addition to the chemokine macrophage inflammatory protein-1alpha P increases receptor affinities and HIV inhibition.
Townson JR; Graham GJ; Landau NR; Rasala B; Nibbs RJ
J Biol Chem; 2000 Dec; 275(50):39254-61. PubMed ID: 11005816
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of the chemokine receptor, CCR5.
Mueller A; Mahmoud NG; Goedecke MC; McKeating JA; Strange PG
Br J Pharmacol; 2002 Feb; 135(4):1033-43. PubMed ID: 11861332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
